Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Scarborough ME, Worcester MA, Hartford CT, Norwalk CT,
Sponsor: Massive Bio, Inc.

Sex: All

Age: 0+

Code: NCT03452774

Recruiting
Active & Responsive

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Philadelphia PA, Fairfax VA, Orlando FL,
Sponsor: Tasca Therapeutics

Sex: All

Age: 18+

Code: NCT07030257

Phase 1, Phase 2, Recruiting
Active & Responsive

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Hartford CT, New York NY, Englewood NJ, Florham Park NJ,
Sponsor: VM Oncology, LLC

Sex: All

Age: 18 - 70+

Code: NCT03556228

Phase 1, Phase 2, Recruiting
Active & Responsive

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: New York NY, Belleville NJ, East Brunswick NJ,
Sponsor: Immuneering Corporation

Sex: All

Age: 18+

Code: NCT07562152

Phase 3, Recruiting
Active & Responsive

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

for
Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer
Location: Columbus OH
Sponsor: Ashish Manne

Sex: All

Age: 18+

Code: NCT05624918

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Pancreatic Cancer Detection Consortium

for
Pancreatic Cancer, Pancreatic Carcinoma,
Location: Morristown NJ, Pittsburgh PA, Rock Hill SC,
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06388967

Recruiting
Active & Responsive

Quebec Pancreas Cancer Study

for
Pancreas Cancer, Pancreatic Cancer, Pancreas Neoplasm,
Location: Montreal
Sponsor: George Zogopoulos

Sex: All

Age: 18+

Code: NCT04104230

Recruiting
Active & Responsive

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

for
Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV,
Location: Norwalk CT
Sponsor: Nuvance Health

Sex: All

Age: 18+

Code: NCT04406831

Recruiting
Active & Responsive

Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Providence RI, Jacksonville FL, Tampa FL, Rochester MN,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07805954

Phase 3, Recruiting
Active & Responsive

A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.

for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Detroit MI, Houston TX, Santa Fe NM, Irvine CA,
Sponsor: Xerient Pharma

Sex: All

Age: 18+

Code: NCT07157033

Phase 1, Phase 2, Recruiting
Active & Responsive

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

for
Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06648434

Phase 1, Recruiting
Active & Responsive

Increasing Germline Genetic Testing for Patients With Cancer

for
Hereditary Pancreatic Cancer, Conditions or Focus of Study,
Location: Danville PA, Durham NC, Salisbury NC, Orlando FL,
Sponsor: Josh Peterson

Sex: All

Age: 0+

Code: NCT07307664

Recruiting
Active & ResponsiveNew

First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer

for
Pancreatic Cancer, Pancreatic Acinar Carcinoma
Location: Houston TX
Sponsor: ParVation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07756281

Phase 1, Recruiting
Active & Responsive

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

for
Cyst of Pancreas, Pancreatectomy, Pancreas Neoplasm
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05720338

Phase 3, Recruiting
Active & Responsive

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: New York NY, East Brunswick NJ, Philadelphia PA,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07277413

Phase 1, Recruiting
Active & Responsive

The Cancer of the Pancreas Screening-5 CAPS5)Study

for
Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT02000089

Phase 3, Recruiting
Active & Responsive

Prehabilitation in High-risk Oncologic Surgery

for
Pancreatic Cancer, Colo-rectal Cancer, Gastric Cancer,
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT07638410

Recruiting
Active & Responsive

CREO - Microwave Ablation Feasibility Study

for
Pancreatic Cancer,
Location: Gilbert AZ
Sponsor: Banner Health

Sex: All

Age: 18+

Code: NCT07817147

Recruiting
Active & Responsive

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

for
Borderline Resectable/Unresectable Pancreatic Cancer,
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: All

Age: 18+

Code: NCT07539155

Phase 1, Phase 2, Recruiting
Active & Responsive

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

for
Pancreatic Cancer
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06893276

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial